Meetings & Events

Hypophosphatemia: Unlocking the Key To Improved Diagnosis and Management

August 26, 2020

An Ancillary Symposium at CEU 2020

Symposium Details: 2:30–3:30 PM EDT on September 11, 2020; certified for 1.0 AMA PRA Category 1 Credit™ and ABIM MOC point.

Co-Chairs: Michael A. Levine, MD
Leanne M. Ward, MD

This clinical program will focus on clinical presentations on the state of care, challenges, and emerging therapies of Hypophosphatemia.

  • X-linked Hypophosphatemia Update: History and Future Goals of Treatment
  • Tumor-Induced Osteomalacia Diagnosis and Imaging
  • Tumor-Induced Osteomalacia Management and Therapeutic Goals
  • Patient Perspective
  • Audience Q&A with Patient and Expert Faculty

Registration is complimentary and open to anyone with Endocrine Society login credentials. You can select to add this symposium to an existing EBR and/or CEU registration or register for it as a standalone event. Simply click the button below and proceed through the prompts.

We thank Ultragenyx Pharmaceuticals for supporting this program.

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.